A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE.
Zhang J, Li H, Gao D, Zhang B, Zheng M, Lun M, Wei M, Duan R, Guo M, Hua J, Liu Q, Bai J, Liu H, Zheng J, Yao H.
Zhang J, et al. Among authors: zhang b.
Cancer Biol Ther. 2018 Jun 3;19(6):475-483. doi: 10.1080/15384047.2018.1433501. Epub 2018 Mar 6.
Cancer Biol Ther. 2018.
PMID: 29400599
Free PMC article.